[PDF] Top 20 Rev. Bras. Ginecol. Obstet. vol.37 número6
Has 10000 "Rev. Bras. Ginecol. Obstet. vol.37 número6" found on our website. Below are the top 20 most common "Rev. Bras. Ginecol. Obstet. vol.37 número6".
Rev. Bras. Ginecol. Obstet. vol.37 número6
... 1. Spong CY, Berghella V, Wenstrom KD, Mercer BM, Saade GR. Preventing the irst cesarean delivery: summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for ... See full document
3
Rev. Bras. Ginecol. Obstet. vol.37 número6
... Patient and disease characteristics, including age, parity and hCG serum level before treatment, FIGO 2002 anatomic staging and risk score, response rate with irst- line single-agent C[r] ... See full document
8
Rev. Bras. Ginecol. Obstet. vol.37 número6
... and incubated at 37°C, for 24 hours. The cells were washed in the following day with PBS and treated with acetaminophen at concentrations ranging from 1.5 to 15 μg/mL, or ibuprofen at 2.0 to 20 μg/mL. Control ... See full document
8
Rev. Bras. Ginecol. Obstet. vol.20 número6
... Com exercício físico aeróbio isolado, ocorreu redução da porcentagem de gordura corporal e queda do colesterol total, LDL, VLDL e dos triglicerídeos, ao passo que o HDL, o IMC e a RCQ nã[r] ... See full document
2
Rev. Bras. Ginecol. Obstet. vol.37 número2
... Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer signiicantly increases in vitro fertilization implantation and delivery rates: a randomized controlle[r] ... See full document
6
Rev. Bras. Ginecol. Obstet. vol.37 número4
... Herlyn-Werner-Wunderlich (HWW) syndrome is a rare congenital disorder of the Müllerian ducts in which there is uterus didelphys, obstructed hemivagina and unilateral renal agenesis.. Th[r] ... See full document
5
Rev. Bras. Ginecol. Obstet. vol.37 número3
... Seu uso foi iniciado para a investigação do aborto recorrente na década de 1990, mas o fato de que a reação se mostrava negativa em mais do que 90% dos casais com perda gestacional e [r] ... See full document
4
Rev. Bras. Ginecol. Obstet. vol.37 número3
... Herein, we verify whether paraspinal anesthetic block reduces the verbal analog scale (VAS) pain scores in patients with CPP refractory to drug therapy.. Our results showed a signiica[r] ... See full document
5
Rev. Bras. Ginecol. Obstet. vol.37 número3
... 14. Kars B, Buyukbayrak EE, Karsidag AY, Pirimoglu M, Unal O, Turan C. Comparison of success rates of transvaginal aspiration and tetracycline sclerotherapy versus only aspiration in the management of non- neoplastic ... See full document
4
Rev. Bras. Ginecol. Obstet. vol.37 número3
... For these reasons, the aims of this study were to evaluate fatigue and qual‑ ity of life in disease‑free Brazilian breast cancer survivors who completed treatment compared with age‑mat[r] ... See full document
8
Rev. Bras. Ginecol. Obstet. vol.37 número3
... Fetal bradycardia and tachycardia did not occur in the present study, probably due to the intermittent characteristic of the resistance exercise, in addition to the small amount of ti[r] ... See full document
7
Rev. Bras. Ginecol. Obstet. vol.37 número1
... A recent large case series with 22 Canadian and 70 American women provided better results. For the group of the Canadians cohort, the live birth rate (86.4%) was signiicantly higher than the rate in the American cohort ... See full document
5
Rev. Bras. Ginecol. Obstet. vol.37 número2
... The aim of this study was to investigate polymor- phisms in genes that encode enzymes involved in folate- and vitamin B12-dependent homocysteine metabolisms, such as C677T and A1298C in[r] ... See full document
6
Rev. Bras. Ginecol. Obstet. vol.37 número1
... The most widely insulin-sensitizing agent used for women with PCOS presenting metabolic syndrome, obesity or impaired glucose tolerance is metformin, in great part because of its impa[r] ... See full document
4
Rev. Bras. Ginecol. Obstet. vol.37 número4
... Normal or below-normal pre-pregnancy BMI, physical activity and adequate weight gain during pregnancy, lower parity, exclusive breastfeeding for a longer period, appropriate or low cal[r] ... See full document
8
Rev. Bras. Ginecol. Obstet. vol.37 número1
... Despite all our efforts to prevent and mitigate both measurement bias and confounding, we recognize that some characteristics of design and methodology may have inluenced the application or interpretation of the results ... See full document
6
Rev. Bras. Ginecol. Obstet. vol.37 número1
... Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy. Osborne RJ, Filiac[r] ... See full document
10
Rev. Bras. Ginecol. Obstet. vol.20 número6
... A Federação Brasileira das Sociedades de Obstetrícia e Ginecologia além de seu papel fundamental de promover a atualização e universalização de conhecimentos entre seus associados e de l[r] ... See full document
1
Rev. Bras. Ginecol. Obstet. vol.20 número6
... Foram avaliadas 60 pacientes portadoras de câncer de mama localmente avançado, estádio IIIA, divididas em dois grupos, que foram submetidas à quimioterapia primária, com ou sem intensifi[r] ... See full document
1
Rev. Bras. Ginecol. Obstet. vol.37 número4
... We focused our discussion on about 10 genes, and we speculated why they are up or downregulated, and how these differences in expression levels can account for the anovulatory phenoty[r] ... See full document
6
temas relacionados